Literature DB >> 21490091

Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase.

Jean-François Gélinas1, Guerline Clerzius, Eileen Shaw, Anne Gatignol.   

Abstract

Adenosine deaminase acting on RNA 1 (ADAR1) is a double-stranded RNA binding protein and RNA-editing enzyme that modifies cellular and viral RNAs, including coding and noncoding RNAs. This interferon (IFN)-induced protein was expected to have an antiviral role, but recent studies have demonstrated that it promotes the replication of many RNA viruses. The data from these experiments show that ADAR1 directly enhances replication of hepatitis delta virus, human immunodeficiency virus type 1, vesicular stomatitis virus, and measles virus. The proviral activity of ADAR1 occurs through two mechanisms: RNA editing and inhibition of RNA-activated protein kinase (PKR). While these pathways have been found independently, the two mechanisms can act in concert to increase viral replication and contribute to viral pathogenesis. This novel type of proviral regulation by an IFN-induced protein, combined with some antiviral effects of hyperediting, sheds new light on the importance of ADAR1 during viral infection and transforms our overall understanding of the innate immune response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490091      PMCID: PMC3165853          DOI: 10.1128/JVI.00240-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  91 in total

1.  Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection.

Authors:  S Balachandran; P C Roberts; L E Brown; H Truong; A K Pattnaik; D R Archer; G N Barber
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

Review 2.  A-to-I RNA editing and human disease.

Authors:  Stefan Maas; Yukio Kawahara; Kristen M Tamburro; Kazuko Nishikura
Journal:  RNA Biol       Date:  2006-01-12       Impact factor: 4.652

Review 3.  VSV-tumor selective replication and protein translation.

Authors:  Glen N Barber
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

Review 4.  Multiple levels of PKR inhibition during HIV-1 replication.

Authors:  Guerline Clerzius; Jean-François Gélinas; Anne Gatignol
Journal:  Rev Med Virol       Date:  2010-12-07       Impact factor: 6.989

Review 5.  Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.

Authors:  Charles E Samuel
Journal:  Virology       Date:  2011-01-05       Impact factor: 3.616

Review 6.  Vesicular stomatitis virus as an oncolytic vector.

Authors:  Glen N Barber
Journal:  Viral Immunol       Date:  2004       Impact factor: 2.257

Review 7.  Functions and regulation of RNA editing by ADAR deaminases.

Authors:  Kazuko Nishikura
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

8.  Adenosine deaminase ADAR1 increases gene expression at the translational level by decreasing protein kinase PKR-dependent eIF-2alpha phosphorylation.

Authors:  Ying Wang; Charles E Samuel
Journal:  J Mol Biol       Date:  2009-09-03       Impact factor: 5.469

9.  RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment.

Authors:  Zhiqun Li; Karen C Wolff; Charles E Samuel
Journal:  Virology       Date:  2009-11-12       Impact factor: 3.616

10.  Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1.

Authors:  Swee Kee Wong; David W Lazinski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-24       Impact factor: 11.205

View more
  52 in total

Review 1.  Biological significance of RNA editing in cells.

Authors:  Wei Tang; Yongjun Fei; Michael Page
Journal:  Mol Biotechnol       Date:  2012-09       Impact factor: 2.695

2.  Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.

Authors:  Zhiqun Li; Kristina M Okonski; Charles E Samuel
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

3.  The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR.

Authors:  Viraj R Sanghvi; Laura F Steel
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

4.  Ubiquitin-dependent Turnover of Adenosine Deaminase Acting on RNA 1 (ADAR1) Is Required for Efficient Antiviral Activity of Type I Interferon.

Authors:  Lemin Li; Guanghui Qian; Yibo Zuo; Yukang Yuan; Qiao Cheng; Tingting Guo; Jin Liu; Chang Liu; Liting Zhang; Hui Zheng
Journal:  J Biol Chem       Date:  2016-10-11       Impact factor: 5.157

5.  Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection.

Authors:  Alessia Ruggieri; Eva Dazert; Philippe Metz; Sarah Hofmann; Jan-Philip Bergeest; Johanna Mazur; Peter Bankhead; Marie-Sophie Hiet; Stephanie Kallis; Gualtiero Alvisi; Charles E Samuel; Volker Lohmann; Lars Kaderali; Karl Rohr; Michael Frese; Georg Stoecklin; Ralf Bartenschlager
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

6.  Reovirus-mediated induction of ADAR1 (p150) minimally alters RNA editing patterns in discrete brain regions.

Authors:  Jennifer L Hood; Michael V Morabito; Charles R Martinez; James A Gilbert; Elizabeth A Ferrick; Gregory D Ayers; James D Chappell; Terence S Dermody; Ronald B Emeson
Journal:  Mol Cell Neurosci       Date:  2014-06-04       Impact factor: 4.314

Review 7.  Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response.

Authors:  Christian K Pfaller; Zhiqun Li; Cyril X George; Charles E Samuel
Journal:  Curr Opin Immunol       Date:  2011-09-15       Impact factor: 7.486

8.  Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR.

Authors:  Shili Zhou; Chao Yang; Fanfan Zhao; Yanxia Huang; Yuxia Lin; Changbai Huang; Xiaocao Ma; Jingjie Du; Yi Wang; Gang Long; Junfang He; Chao Liu; Ping Zhang
Journal:  J Biol Chem       Date:  2019-10-21       Impact factor: 5.157

9.  Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.

Authors:  Hachung Chung; Jorg J A Calis; Xianfang Wu; Tony Sun; Yingpu Yu; Stephanie L Sarbanes; Viet Loan Dao Thi; Abigail R Shilvock; H-Heinrich Hoffmann; Brad R Rosenberg; Charles M Rice
Journal:  Cell       Date:  2018-01-25       Impact factor: 41.582

10.  STAT2-dependent induction of RNA adenosine deaminase ADAR1 by type I interferon differs between mouse and human cells in the requirement for STAT1.

Authors:  Cyril X George; Charles E Samuel
Journal:  Virology       Date:  2015-08-31       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.